ArticleHuman vaccines & immunotherapeutics2013

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.

Rosalind Rowland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.